# Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

Study · id `cardio:ct-nct05732727` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05732727](<https://clinicaltrials.gov/study/NCT05732727>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05732727

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 720 participants.

## Technical summary

Registry record NCT05732727. Randomized; no masking; primary purpose treatment. Start 2023-03-28 (actual); primary completion 2029-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 720 participants (planned count; ClinicalTrials.gov record NCT05732727, source copy `cardio:ctgov-nct05732727-2026-08-03`, retrieved 2026-10-26)
- Started: 2023-03-28 (actual) (ClinicalTrials.gov record NCT05732727, source copy `cardio:ctgov-nct05732727-2026-08-03`, retrieved 2026-10-26)
- Primary completion: 2029-03 (anticipated) (ClinicalTrials.gov record NCT05732727, source copy `cardio:ctgov-nct05732727-2026-08-03`, retrieved 2026-10-26)
- Completion: 2029-03 (anticipated) (ClinicalTrials.gov record NCT05732727, source copy `cardio:ctgov-nct05732727-2026-08-03`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT05732727, source copy `cardio:ctgov-nct05732727-2026-08-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05732727-2026-08-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
- Acronym: THINK
- Condition: Chronic Kidney Disease(CKD)
- Condition: Uncontrolled Hypertension
- Intervention (Drug): Antihypertensive algorithm
- Intervention (Drug): Standard of care
- Lead sponsor: University Hospital, Tours
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: a9ac3402192e3b48c21448db6c58cb6af9ae7bb29517866c8484e3b23a0ec187
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
